United Therapeutics Corporation (UTHR)

United Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1,208	961.2	894.8	738.7	738.4
Short-Term Investments	1,786	1,878	1,036	1,096	747.5
Cash & Cash Equivalents	2,994	2,839	1,931	1,835	1,486
Cash Growth	5.47%	47.03%	5.22%	23.49%	4.94%
Receivables	278.9	220.4	198.7	157.4	151.4
Inventory	111.8	102	93.8	86.5	93.4
Other Current Assets	166.2	219.2	100.4	88.3	133.8
Total Current Assets	3,551	3,380	2,324	2,167	1,865
Property, Plant & Equipment	1,045	861.5	780.9	731.6	738.5
Long-Term Investments	1,910	1,316	1,650	1,150	767.5
Goodwill and Intangibles	114.2	44.5	44.6	158.1	158.3
Other Long-Term Assets	546.6	442	370.1	408.5	384.6
Total Long-Term Assets	3,616	2,664	2,846	2,448	2,049
Total Assets	7,167	6,045	5,169	4,615	3,913
Accounts Payable	298	229.9	174.6	187	148.4
Current Debt	400	0	0	0	250
Other Current Liabilities	106.4	113.3	130.8	136.3	64.6
Total Current Liabilities	804.4	343.2	305.4	323.3	463
Long-Term Debt	300	800	800	800	600
Other Long-Term Liabilities	77.8	104.6	104.8	96.5	70
Total Long-Term Liabilities	377.8	904.6	904.8	896.5	670
Total Liabilities	1,182	1,248	1,210	1,220	1,133
Total Debt	700	800	800	800	850
Debt Growth	-12.50%	-	-	-5.88%	240.00%
Retained Earnings	6,027	5,042	4,315	3,839	3,325
Comprehensive Income	-12.8	-55.5	-23	-14.2	-14.2
Shareholders' Equity	5,985	4,797	3,959	3,395	2,780
Net Cash / Debt	2,294	2,039	1,131	1,035	635.9
Net Cash / Debt Growth	12.53%	80.30%	9.25%	62.76%	-45.46%
Net Cash Per Share	46.16	42.04	23.90	23.21	14.52
Working Capital	2,747	3,037	2,018	1,844	1,402
Book Value Per Share	127.88	105.42	88.17	76.81	63.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).